Nifty
Sensex
:
:
24530.90
80604.65
-269.95 (-1.09%)
-738.81 (-0.91%)

Pharmaceuticals & Drugs - Global

Rating :
36/99

BSE: 531146 | NSE: MEDICAMEQ

502.65
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  510.00
  •  512.25
  •  498.05
  •  513.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  21470
  •  108.46
  •  845.00
  •  355.45

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 578.13
  • 54.15
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 594.16
  • 0.22%
  • 3.06

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.99%
  • 3.09%
  • 31.57%
  • FII
  • DII
  • Others
  • 0.06%
  • 0.00%
  • 22.29%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.53
  • 2.82
  • 7.71

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.75
  • 6.87
  • 4.34

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 66.80
  • 4.13
  • 6.69

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 56.23
  • 56.89
  • 57.13

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.92
  • 5.17
  • 5.28

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 32.32
  • 34.07
  • 35.13

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
47.32
38.66
22.40%
46.50
35.58
30.69%
43.54
33.53
29.85%
41.94
33.09
26.75%
Expenses
41.57
32.17
29.22%
41.61
29.71
40.05%
38.90
27.68
40.53%
34.99
27.43
27.56%
EBITDA
5.75
6.49
-11.40%
4.89
5.88
-16.84%
4.65
5.85
-20.51%
6.95
5.66
22.79%
EBIDTM
12.16%
16.79%
10.52%
16.51%
10.67%
17.44%
16.57%
17.10%
Other Income
0.57
0.35
62.86%
0.83
0.63
31.75%
0.55
0.53
3.77%
0.38
0.96
-60.42%
Interest
1.89
0.86
119.77%
0.65
0.68
-4.41%
0.91
0.62
46.77%
0.96
0.77
24.68%
Depreciation
1.77
1.62
9.26%
1.81
1.60
13.12%
1.82
1.61
13.04%
1.69
1.53
10.46%
PBT
2.66
4.36
-38.99%
3.27
4.22
-22.51%
2.46
4.14
-40.58%
4.68
4.33
8.08%
Tax
0.62
0.59
5.08%
1.24
0.45
175.56%
0.99
0.54
83.33%
0.74
0.74
0.00%
PAT
2.04
3.77
-45.89%
2.03
3.77
-46.15%
1.48
3.60
-58.89%
3.95
3.59
10.03%
PATM
4.32%
9.75%
4.37%
10.60%
3.39%
10.75%
9.41%
10.84%
EPS
1.67
3.07
-45.60%
1.60
2.98
-46.31%
1.76
2.85
-38.25%
3.30
2.94
12.24%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Net Sales
179.30
140.87
115.45
112.72
125.50
122.60
Net Sales Growth
27.29%
22.02%
2.42%
-10.18%
2.37%
 
Cost Of Goods Sold
92.59
53.25
43.51
50.06
65.62
69.26
Gross Profit
86.71
87.62
71.93
62.65
59.89
53.34
GP Margin
48.36%
62.20%
62.30%
55.58%
47.72%
43.51%
Total Expenditure
157.07
116.53
91.36
93.04
106.03
105.14
Power & Fuel Cost
-
5.67
5.86
2.68
2.90
2.11
% Of Sales
-
4.02%
5.08%
2.38%
2.31%
1.72%
Employee Cost
-
20.15
14.50
9.00
9.52
8.09
% Of Sales
-
14.30%
12.56%
7.98%
7.59%
6.60%
Manufacturing Exp.
-
27.14
18.12
26.48
21.99
19.85
% Of Sales
-
19.27%
15.70%
23.49%
17.52%
16.19%
General & Admin Exp.
-
5.67
4.93
2.76
3.92
3.29
% Of Sales
-
4.02%
4.27%
2.45%
3.12%
2.68%
Selling & Distn. Exp.
-
3.48
3.36
1.71
1.77
2.33
% Of Sales
-
2.47%
2.91%
1.52%
1.41%
1.90%
Miscellaneous Exp.
-
1.18
1.07
0.34
0.32
0.22
% Of Sales
-
0.84%
0.93%
0.30%
0.25%
0.18%
EBITDA
22.24
24.34
24.09
19.68
19.47
17.46
EBITDA Margin
12.40%
17.28%
20.87%
17.46%
15.51%
14.24%
Other Income
2.33
2.46
1.72
0.75
1.94
3.66
Interest
4.41
3.39
1.94
1.51
0.93
1.38
Depreciation
7.09
6.37
5.77
2.52
2.50
2.21
PBT
13.07
17.05
18.09
16.39
17.98
17.52
Tax
3.59
2.32
3.20
4.26
4.69
5.50
Tax Rate
27.47%
13.61%
17.69%
25.99%
26.08%
31.39%
PAT
9.50
14.73
14.90
12.13
13.29
12.03
PAT before Minority Interest
10.57
14.73
14.90
12.13
13.29
12.03
Minority Interest
1.07
0.00
0.00
0.00
0.00
0.00
PAT Margin
5.30%
10.46%
12.91%
10.76%
10.59%
9.81%
PAT Growth
-35.51%
-1.14%
22.84%
-8.73%
10.47%
 
EPS
7.48
11.60
11.73
9.55
10.46
9.47

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
193.29
146.47
132.89
121.22
86.63
Share Capital
12.65
12.22
12.22
12.22
11.70
Total Reserves
180.64
134.25
120.67
109.00
74.93
Non-Current Liabilities
0.65
6.04
7.84
3.58
1.42
Secured Loans
0.87
5.07
6.40
2.36
0.02
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.66
1.46
1.16
1.06
0.98
Current Liabilities
82.57
72.69
53.27
56.48
48.54
Trade Payables
47.59
43.30
32.21
37.38
30.57
Other Current Liabilities
7.28
5.03
4.90
5.91
0.78
Short Term Borrowings
23.31
19.27
10.93
7.62
11.61
Short Term Provisions
4.39
5.09
5.23
5.57
5.58
Total Liabilities
276.63
225.20
194.00
181.28
136.59
Net Block
92.66
92.48
89.64
33.69
24.38
Gross Block
130.43
124.26
115.66
57.74
46.58
Accumulated Depreciation
37.77
31.78
26.02
24.05
22.20
Non Current Assets
106.22
94.42
91.31
75.11
40.01
Capital Work in Progress
0.00
0.00
0.00
40.50
14.76
Non Current Investment
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
1.11
0.87
0.78
0.63
0.58
Other Non Current Assets
12.46
1.08
0.90
0.29
0.29
Current Assets
163.36
123.04
96.03
104.13
96.17
Current Investments
0.00
0.00
0.00
0.00
0.00
Inventories
45.06
27.01
5.20
16.96
15.26
Sundry Debtors
65.26
63.22
52.55
49.96
43.37
Cash & Bank
20.78
3.82
3.89
3.09
8.52
Other Current Assets
32.27
20.28
22.95
21.52
29.01
Short Term Loans & Adv.
10.22
8.69
11.44
12.60
14.41
Net Current Assets
80.79
50.35
42.76
47.65
47.62
Total Assets
276.64
225.20
194.00
181.28
136.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
-6.29
4.11
12.77
12.80
4.30
PBT
17.05
18.09
16.39
17.98
17.35
Adjustment
8.56
7.04
3.43
2.81
2.24
Changes in Working Capital
-28.78
-17.82
-2.59
-3.64
-11.29
Cash after chg. in Working capital
-3.17
7.31
17.23
17.15
8.30
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-3.12
-3.20
-4.46
-4.35
-4.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5.88
-8.47
-17.81
-37.29
-14.76
Net Fixed Assets
-5.86
-8.60
-17.42
-36.90
Net Investments
-2.02
0.00
0.00
-2.06
Others
2.00
0.13
-0.39
1.67
Cash from Financing Activity
29.13
4.30
5.84
19.06
-3.69
Net Cash Inflow / Outflow
16.95
-0.07
0.80
-5.43
-14.15
Opening Cash & Equivalents
3.82
3.89
3.09
8.52
22.66
Closing Cash & Equivalent
20.78
3.82
3.89
3.09
8.52

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
147.21
113.56
103.33
97.55
73.69
ROA
5.87%
7.11%
6.46%
8.36%
8.80%
ROE
9.06%
11.25%
9.89%
12.94%
13.95%
ROCE
10.86%
12.94%
12.99%
16.54%
19.30%
Fixed Asset Turnover
1.11
0.96
1.30
2.41
2.63
Receivable days
166.45
183.01
165.97
135.71
129.12
Inventory Days
93.37
50.92
35.88
46.85
45.43
Payable days
311.49
316.67
253.69
117.21
106.58
Cash Conversion Cycle
-51.67
-82.73
-51.84
65.35
67.97
Total Debt/Equity
0.14
0.19
0.15
0.10
0.14
Interest Cover
6.03
10.32
11.85
20.30
13.68

News Update:


  • Medicamen Biotech’s Bhiwadi Formulation facility completes EU GMP Inspection
    31st May 2024, 13:00 PM

    The inspection closed with some procedural observations which will be well responded within Stipulated time

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.